Adipose-derived stem cells from diabetic mice show impaired vascular stabilization in a murine model of diabetic retinopathy

Stem Cells Translational Medicine

Volumn 4, Issue 5, 2015, Pages 459-467

  Cronk, Stephen M ^a   Kelly Goss, Molly R ^a   Ray, H Clifton ^a   Mendel, Thomas A ^b   Hoehn, Kyle L ^b   Bruce, Anthony C ^a   Dey, Bijan K ^b   Guendel, Alexander M ^a,b   Tavakol, Daniel N ^a   Herman, Ira M ^c   Peirce, Shayn M ^a,b   Yates, Paul A ^a,b  

^a University of Virginia   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adipose derived stem cells; Diabetes; Diabetic retinopathy; Pericyte; Stem cells

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; MONOCYTE CHEMOTACTIC PROTEIN 1; OSTEOPONTIN; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; STROMAL CELL DERIVED FACTOR 1; THROMBOSPONDIN 2; CULTURE MEDIUM;

ADIPOSE DERIVED STEM CELL; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS ASSAY; ARTICLE; BIOENERGY; CELL PROLIFERATION ASSAY; CELL VIABILITY; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; INJECTION; MALE; MONTE CARLO METHOD; MOUSE; NONHUMAN; RETINA BLOOD VESSEL; STEM CELL TRANSPLANTATION; SUBRETINAL NEOVASCULARIZATION; TUNEL ASSAY; VASCULAR FRAGILITY; ADIPOCYTE; ANIMAL; BIOLOGICAL THERAPY; CULTURE MEDIUM; CYTOLOGY; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODEL; PATHOLOGY; STEM CELL;

MURINAE; MUS;

ADIPOCYTES; ANIMALS; CELL- AND TISSUE-BASED THERAPY; CULTURE MEDIA, CONDITIONED; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; DISEASE MODELS, ANIMAL; MICE; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 84930421723     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2014-0108     Document Type: Article

References (48)

1. Fadini GP, Avogaro A. Diabetes impairs mobilization of stem cells for the treatment of cardiovascular disease:A meta-regression analysis. Int J Cardiol 2013;168:892–897.
2. Leu S, Lin YC, Yuen CM et al. Adipose-derived mesenchymal stem cells markedly attenuate brain infarct size and improve neurological function in rats. J Transl Med 2010; 8:63.
3. Zografou A, Papadopoulos O, Tsigris C et al. Autologous transplantation of adipose-derived stem cells enhances skin graft survival and wound healing in diabetic rats. Ann Plast Surg 2013;71:225–232.
4. Cianfarani F, Toietta G, Di Rocco G et al. Diabetes impairs adipose tissue-derived stem cell function and efficiencyinpromoting wound healing. Wound Repair Regen 2013;21:545–553.
5. Kočí Z, Turnovcová K, DubskΎ M et al. Char-acterization of human adipose tissue-derived stromal cells isolated from diabetic patient’s distal limbs with critical ischemia. Cell Biochem Funct 2014;32:597–604.
6. Tamarat R, Silvestre JS, Le Ricousse-Roussanne S et al. Impairment in ischemia-induced neovascularization in diabetes: Bone marrow mononuclear cell dysfunction and therapeutic potential of placenta growth factor treatment. Am J Pathol 2004;164: 457–466.
7. Mendel TA, Clabough EB, Kao DS et al. Pericytes derived from adipose-derived stem cells protect against retinal vasculopathy. PLoS One 2013;8:e65691.
8. Zuk PA, Zhu M, Mizuno H et al. Multiline-age cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng 2001; 7:211–228.
9. Keats EC, Khan ZA. Vascular stem cells in diabetic complications: Evidence for a role in the pathogenesis and the therapeutic promise. Cardiovasc Diabetol 2012;11:37.
10. Heng LZ, Comyn O, Peto T et al. Diabetic retinopathy: Pathogenesis, clinical grading, management and future developments. Diabet Med 2013;30:640–650.
11. Gardner TW, Antonetti DA, Barber AJ et al. New insights into the pathophysiology of diabetic retinopathy: Potential cell-specific therapeutic targets. Diabetes Technol Ther 2000;2:601–608.
12. Hammes HP, Lin J, Renner O et al. Peri-cytes and the pathogenesis of diabetic retinop-athy. Diabetes 2002;51:3107–3112.
13. Nguyen QD, Brown DM, Marcus DM et al. Ranibizumab for diabetic macular edema: Results from 2 phase III randomized trials: RISE and RIDE. Ophthalmology 2012; 119:789–801.
14. Han Z, Guo J, Conley SM et al. Retinal an-giogenesis in the Ins2 (Akita) mouse model of diabetic retinopathy. Invest Ophthalmol Vis Sci 2013;54:574–584.
15. Rakoczy EP, Ali Rahman IS, Binz N et al. Characterization of a mouse model of hypergly-cemia and retinal neovascularization. Am J Pathol 2010;177:2659–2670.
16. van Eeden PE, Tee LB, Lukehurst S et al. Early vascular and neuronal changes in a VEGF transgenic mouse model of retinal neovascula-rization. Invest Ophthalmol Vis Sci 2006;47: 4638–4645.
17. Amos PJ, Kapur SK, Stapor PC et al. Human adipose-derived stromal cells accelerate diabetic wound healing: Impact of cell formulation and delivery. Tissue Eng Part A 2010;16:1595–1606.
18. Amos PJ, Mulvey CL, Seaman SA et al. Hypoxic culture and in vivo inflammatory environments affect the assumption of pericyte characteristics by human adipose and bone marrow progenitor cells. AmJPhysiol Cell Phys-iol 2011;301:C1378–C1388.
19. Amos PJ, Shang H, Bailey AM et al. IFATS collection: The role of human adipose-derived stromal cells in inflammatory microvascular remodeling and evidenceof a perivascular phe-notype. Stem Cells 2008;26:2682–2690.
20. Kelly-Goss MR, Sweat RS, Stapor PCet al. Targeting pericytes for angiogenic therapies. Microcirculation 2014;21:345–357.
21. Kenwood BM, Weaver JL, Bajwa A et al. Identification of a novelmitochondrial uncou-pler that does not depolarize the plasma membrane. Mol Metabolism 2013;3:114–123.
22. Ebrahimian TG, Pouzoulet F, Squiban C et al. Cell therapy based on adipose tissue-derived stromal cells promotes physiological and pathological wound healing. Arterioscler Thromb Vasc Biol 2009;29:503–510.
23. Takakura N, Watanabe T, Suenobu S et al. A role for hematopoietic stem cells in promoting angiogenesis. Cell 2000;102:199–209.
24. Mizuno H. Adipose-derived stem cells for tissue repair and regeneration: Ten years of research and a literature review. J Nippon Med Sch 2009;76:56–66.
25. Shin L, Peterson DA. Impaired therapeutic capacity of autologous stem cells in a model of type 2 diabetes. Stem Cells Translational Medicine 2012;1:125–135.
26. Salamon A, Adam S, Rychly J et al. Long-term tumor necrosis factor treatment induces NFkB activation and proliferation, but not osteoblastic differentiation of adipose tissue-derived mesenchymal stem cells in vitro. Int J Biochem Cell Biol 2014;54:149–162.
27. Winkler EA, Bell RD, Zlokovic BV. Central nervous system pericytesin health and disease. Nat Neurosci 2011;14:1398–1405.
28. Traktuev DO, Merfeld-Clauss S, Li J et al. A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchy-mal surface markers, reside in a periendothelial location, and stabilize endothelial networks. Circ Res 2008;102:77–85.
29. Cai X, Lin Y, Hauschka PV et al. Adipose stem cells originate from perivascular cells. Biol Cell 2011;103:435–447.
30. Feng J, Mantesso A, Sharpe PT. Perivas-cular cells as mesenchymal stem cells. Expert Opin Biol Ther 2010;10:1441–1451.
31. Melero-Martin JM, De Obaldia ME, Kang SY et al. Engineering robust and functional vascular networks in vivo with human adult and cord blood-derived progenitor cells. Circ Res 2008;103:194–202.
32. Chen L, Tredget EE, Wu PY et al. Para-crine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PLoS One 2008;3:e1886.
33. Falanga V, Iwamoto S, Chartier M et al. Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds. Tissue Eng 2007;13:1299–1312.
34. Wu Y, Chen L, Scott PG et al. Mesenchy-mal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells 2007;25:2648–2659.
35. Ho JC, Lai WH, Li MF et al. Reversal of en-dothelial progenitor cell dysfunction inpatients with type 2 diabetes using a conditioned medium of human embryonic stem cell-derived endothelial cells. Diabetes Metab Res Rev 2012;28:462–473.
36. Jiang Y, Zhang Q, Steinle JJ. Intravitreal injection of IGFBP-3 restores normal insulin signaling in diabetic rat retina. PLoS One 2014;9: e93788.
37. Rowe GC, Raghuram S, Jang C et al. PGC-1a induces SPP1 to activate macrophages and orchestrate functional angiogenesis in skeletal muscle. Circ Res 2014;115:504–517.
38. Song N, Huang Y, Shi H et al. Overexpres-sion of platelet-derived growth factor-BB increases tumor pericyte content via stromal-derived factor-1alpha/CXCR4 axis. Cancer Res 2009;69:6057–6064.
39. Zhang Q, Jiang Y, Miller MJ et al. IGFBP-3 and TNF-a regulate retinal endothelial cell apoptosis. Invest Ophthalmol Vis Sci 2013;54: 5376–5384.
40. Tsuruma K, Yamauchi M, Sugitani S et al. Progranulin, a major secreted protein of mouse adipose-derived stem cells, inhibits light-induced retinal degeneration. Stem Cells Translational Medicine 2014;3:42–53.
41. Zhang S, Danchuk SD, Imhof KM et al. Comparison of the therapeutic effects of human and mouse adipose-derived stem cells in a murine model of lipopolysaccharide-induced acute lung injury. Stem Cell Res Ther 2013;4:13.
42. Trudeau K, Molina AJ, Roy S. High glucose induces mitochondrial morphology and metabolic changes in retinal pericytes. Invest Ophthalmol Vis Sci 2011;52:8657–8664.
43. Cooper ME, El-Osta A. Epigenetics: Mechanisms and implications for diabetic complications. Circ Res 2010;107:1403–1413.
44. Ling C, Groop L. Epigenetics: A molecular link between environmental factors and type 2 diabetes. Diabetes 2009;58:2718–2725.
45. Paneni F, Costantino S, Volpe M et al. Epi-genetic signatures and vascular risk intype 2 diabetes: A clinical perspective. Atherosclerosis 2013;230:191–197.
46. Prockop DJ, Oh JY. Mesenchymal stem/stromal cells (MSCs): Role as guardians of inflammation. Mol Ther 2012;20:14–20.
47. Anton K, Banerjee D, Glod J. Macrophage-associated mesenchymal stem cells assume an activated, migratory, pro-inflammatory pheno-type with increased IL-6 and CXCL10 secretion. PLoS One 2012;7:e35036.
48. Lutty GA. Effects of diabetes on the eye. Invest Ophthalmol Vis Sci 2013; 54: ORSF81-7.